Parallax Volatility Advisers’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Parallax Volatility Advisers’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-700	Closed	-$1K	–	4008
2018 Q2	$1K	Sell	700 -9,775	-93%	-$16.9K	﹤0.01%	2022
2018 Q1	$19K	Sell	10,475 -58,253	-85%	-$123K	﹤0.01%	1723
2017 Q4	$153K	Buy	68,728 +34,674	+102%	+$86.2K	﹤0.01%	2488
2017 Q3	$99K	Buy	34,054 +33,354	+4,765%	+$114K	﹤0.01%	1587
2017 Q2	$3K	Hold	700	–	–	﹤0.01%	2052
2017 Q1	$3K	Hold	700	–	–	﹤0.01%	3379
2016 Q4	$4K	Hold	700	–	–	﹤0.01%	2882
2016 Q3	$4K	Sell	700 -1,500	-68%	-$7.02K	﹤0.01%	2740
2016 Q2	$8K	Sell	2,200 -23,800	-92%	-$80.7K	﹤0.01%	2389
2016 Q1	$72K	Hold	26,000	–	–	﹤0.01%	2053
2015 Q4	$147K	Buy	26,000 +25,000	+2,500%	+$152K	﹤0.01%	1999
2015 Q3	$5K	Buy	+1,000	New	+$7.74K	﹤0.01%	2655

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Parallax Volatility Advisers's SGYP Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2018, closing a stake of 700 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in SGYP in Q3 2015 and held it in 12 quarters. The position peaked at $153K in Q4 2017. 133 funds tracked by Wall St. Rank hold SGYP as of Q3 2018.

Parallax Volatility Advisers reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 700 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2018, an estimated $1K.
Parallax Volatility Advisers first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 12 quarters.
Parallax Volatility Advisers's Synergy Pharmaceuticals, Inc Common Stock position peaked at $153K in Q4 2017.
133 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.